WO1999058642A3 - Proteines secretees et polynucleotides codant pour ces dernieres - Google Patents

Proteines secretees et polynucleotides codant pour ces dernieres Download PDF

Info

Publication number
WO1999058642A3
WO1999058642A3 PCT/US1999/010843 US9910843W WO9958642A3 WO 1999058642 A3 WO1999058642 A3 WO 1999058642A3 US 9910843 W US9910843 W US 9910843W WO 9958642 A3 WO9958642 A3 WO 9958642A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotides encoding
secreted proteins
proteins
secreted
polynucleotides
Prior art date
Application number
PCT/US1999/010843
Other languages
English (en)
Other versions
WO1999058642A2 (fr
Inventor
Gordon G Wong
Hilary F Clark
Kim Fechtel
Michael J Agostino
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/311,021 external-priority patent/US6706869B1/en
Application filed by Genetics Inst filed Critical Genetics Inst
Priority to EP99924280A priority Critical patent/EP1080180A2/fr
Priority to CA002328062A priority patent/CA2328062A1/fr
Priority to JP2000548435A priority patent/JP2003530296A/ja
Publication of WO1999058642A2 publication Critical patent/WO1999058642A2/fr
Publication of WO1999058642A3 publication Critical patent/WO1999058642A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)

Abstract

La présente invention concerne de nouveaux polynucléotides et les protéines pour lesquelles ils codent.
PCT/US1999/010843 1998-05-14 1999-05-14 Proteines secretees et polynucleotides codant pour ces dernieres WO1999058642A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP99924280A EP1080180A2 (fr) 1998-05-14 1999-05-14 Proteines secretees et polynucleotides codant pour ces dernieres
CA002328062A CA2328062A1 (fr) 1998-05-14 1999-05-14 Proteines secretees et polynucleotides codant pour ces dernieres
JP2000548435A JP2003530296A (ja) 1998-05-14 1999-05-14 分泌蛋白およびそれらをコードするポリヌクレオチド

Applications Claiming Priority (26)

Application Number Priority Date Filing Date Title
US8547298P 1998-05-14 1998-05-14
US60/085,472 1998-05-14
US9682498P 1998-08-17 1998-08-17
US60/096,824 1998-08-17
US9984398P 1998-09-11 1998-09-11
US9995098P 1998-09-11 1998-09-11
US60/099,843 1998-09-11
US60/099,950 1998-09-11
US10042498P 1998-09-15 1998-09-15
US60/100,424 1998-09-15
US10232998P 1998-09-29 1998-09-29
US60/102,329 1998-09-29
US10361598P 1998-10-09 1998-10-09
US60/103,615 1998-10-09
US11179998P 1998-12-11 1998-12-11
US60/111,799 1998-12-11
US11215998P 1998-12-14 1998-12-14
US60/112,159 1998-12-14
US11441598P 1998-12-31 1998-12-31
US60/114,415 1998-12-31
US24805999A 1999-02-10 1999-02-10
US09/248,059 1999-02-10
US28715099A 1999-04-06 1999-04-06
US09/287,150 1999-04-06
US09/311,021 1999-05-13
US09/311,021 US6706869B1 (en) 1998-02-11 1999-05-13 Map kinase phosphatases and polynucleotides encoding them

Publications (2)

Publication Number Publication Date
WO1999058642A2 WO1999058642A2 (fr) 1999-11-18
WO1999058642A3 true WO1999058642A3 (fr) 2000-03-02

Family

ID=27584491

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/010843 WO1999058642A2 (fr) 1998-05-14 1999-05-14 Proteines secretees et polynucleotides codant pour ces dernieres

Country Status (4)

Country Link
EP (1) EP1080180A2 (fr)
JP (1) JP2003530296A (fr)
CA (1) CA2328062A1 (fr)
WO (1) WO1999058642A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083700A (en) 1998-06-26 2000-07-04 Incyte Pharmaceuticals, Inc. Human goose-type lysozyme
EP1117688B1 (fr) 1998-10-09 2005-04-27 Medical College Of Georgia Research Institute, Inc. Proteine modifiant l'activite du recepteur de dopamine de type d1
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
WO2000053636A2 (fr) * 1999-03-08 2000-09-14 Ceptyr, Inc. Phosphatase dsp-1 a double specificite
WO2000060078A2 (fr) * 1999-04-01 2000-10-12 Cold Spring Harbor Laboratory Latheo codant une sous-unite de proteines complexes de reconnaissance d'origine
EP1624061B1 (fr) * 1999-08-03 2009-10-28 Genentech, Inc. Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
CN1377409A (zh) * 1999-08-19 2002-10-30 黑川清 Meg－1蛋白
AU2084601A (en) * 1999-12-10 2001-06-18 Biogen, Inc. Novel polypeptides and polynucleotides encoding same
CA2399569A1 (fr) * 2001-09-25 2003-03-25 Yusuke Nakamura Marqueurs diagnostiques et cibles therapeutiques pour le traitement du cancer
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
CN103596974B (zh) 2011-04-15 2016-08-31 卡姆普根有限公司 多肽和多核苷酸及其用于治疗免疫相关失调和癌症的用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK, Accession No. AA665330, EST nt89a10.sl. 18 February 1998. *

Also Published As

Publication number Publication date
CA2328062A1 (fr) 1999-11-18
EP1080180A2 (fr) 2001-03-07
WO1999058642A2 (fr) 1999-11-18
JP2003530296A (ja) 2003-10-14

Similar Documents

Publication Publication Date Title
WO1998007859A3 (fr) Proteines secretees et polynucleotides codant lesdites proteines
WO1998017687A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1999057132A8 (fr) Proteines secretees et polynucleotides codant pour celles-ci
WO1997007198A3 (fr) Sequences d'adn et proteines secretees codees par celles-ci
WO1998033916A8 (fr) Proteines secretees et polynucleotides codant celles-ci
WO1998042739A3 (fr) Proteines secretees et polynucleotides les codant
WO1998042741A3 (fr) Proteines secretees et polynucleotides les codant
WO1998004693A3 (fr) Proteines secretees et polynucleotides les codant
WO2001075068A3 (fr) Proteines secretee et polynucleotides codant pour ces proteines
WO1998055614A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1998040486A3 (fr) Proteines secretees et polynucleotides les codant
WO1999058642A3 (fr) Proteines secretees et polynucleotides codant pour ces dernieres
WO1998005776A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1998027205A3 (fr) Proteines secretees et polynucleotides codant pour lesdites proteines
WO1998046757A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1998037094A3 (fr) Proteines secretees et polynucleotides les codant
WO1998032853A3 (fr) Proteines secretees et polynucleotides les codant
WO1998040404A3 (fr) Proteines secretees et polynucleotides codant ces dernieres
WO1999035263A3 (fr) Adn codant il-17rh et polypeptides il-17rh
WO1998056909A3 (fr) Proteines secretees et polynucleotides les codant
WO1998030589A3 (fr) Proteines secretees et polynucleotides les codant
WO1998041539A3 (fr) Proteines secretees et polynucleotides les codant
WO1998021332A3 (fr) Proteines secretes et polynucleotides les codant
WO1998038209A3 (fr) Proteines secretees et polynucleotides codant pour celles-ci
WO1998031802A3 (fr) Proteines secretees et polynucleotides codant ces proteines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2328062

Country of ref document: CA

Ref country code: CA

Ref document number: 2328062

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 548435

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999924280

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999924280

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999924280

Country of ref document: EP